Nirmatrelvir reduces the risk of long COVID

05 Mar 2024
Nirmatrelvir reduces the risk of long COVID

Post-COVID condition, also known as long COVID, is a serious public health problem affecting millions of people around the world.1

Long COVID encompasses a wide range of ongoing health problems that may last for weeks, months, or years, and may sometimes result in disability.2 There is currently no approved medication for the prevention or treatment of long-COVID.1

Editor's Recommendations